Back

Risks of thromboembolism, mortality and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: a nationwide cohort study.

23 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Outcome of atrial fibrillation Clinical EHRA Premium Access EHRA 2021

About the speaker

Photo
Associate Professor Daniele Pastori

Sapienza University of Rome, Rome (Italy)

5 More presentations in this session

Presentation thumbnail
The Atrial Fibrillation Better Care (ABC) pathway in atrial fibrillation: a systematic review and meta-analysis of 285,000 patients
Doctor M. Proietti (Milan, IT)
Abstract Slides Video
Presentation thumbnail
CHA2DS2-VASc score in acute coronary syndrome
Doctor H. Santos (Lisboa, PT)
Abstract Slides Video
Presentation thumbnail
Left atrial wall stress and the outcome of catheter ablation for atrial fibrillation: artificial intelligence-based prediction of clinical outcome
Doctor J. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Comparison of bleeding risk scores in patients with atrial fibrillation and cancer.
Assistant Professor D. Pastori (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Atrial Fibrillation in Acute Coronary Syndrome - early onset impact on MACE
Doctor M. Santos (Figueira da Foz, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Outcome of atrial fibrillation

The Event

Event poster

EHRA 2021

23 April - 25 April 2021
You may be interested in
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion
thumbnail
Congress Presentation
Oral anticoagulation in subclinical atrial fibrillation: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources